Paul Sanger interviewed Damian Spring, CEO of Santana Minerals Limited (ASX:SMI), to discuss the Bendigo gold project, which has recently been designated as a fast-track project. Damian highlighted the project's economic potential, projecting 1.1 million ounces of gold over ten years, which could generate significant export earnings and job creation in New Zealand. He mentioned ongoing environmental studies and a feasibility study set for release soon, emphasising the positive impact of rising gold prices on profitability and investor interest.
Copyright 2024 – Finance News Network
03 Dec 2019 - EQT Holdings Limited (ASX:EQT) Managing Director, Mick O'Brien talks FY19 results, market conditions, contribution from recent acquisitions and outlook for 1H20.
26 Apr 2021 - Praemium Limited (ASX:PPS) CEO and Managing Director Michael Ohanessian talks about the company's strong 1H21 results, the successful acquisition of Powerwrap, platform enhancements and outlook.
28 Sep 2020 - Respiri Limited (ASX:RSH) CEO Marjan Mikel discusses clinical results from the company's innovative asthma management tool wheezo, a combination eHealth app and handheld device, as well as the company's strategy and outlook.
21 Nov 2019 - Alpha HPA (ASX:A4N) Managing Director, Rimas Kairaitis provides an update on the company's High Purity Aluminum (HPA) processing technology, pilot plant program and project economics.
01 Jul 2021 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO & Managing Director Dr Michael Baker discusses the company's acquisition of the invariant natural killer T (iNKT) cell therapy platform from Imperial College London.
07 Jun 2021 - Peel Mining Limited (ASX:PEX) Managing Director Rob Tyson talks about the company's projects targeting zinc & copper, drill results, hub and spoke model, and its outlook.
27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
03 Mar 2023 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig discusses the company's half-year financial results, commenting on key drivers, the Lasoo platform launch, the Ovato acquisition and the company's partnership with Iberdrola.
09 Mar 2023 - Sequoia Financial Group Limited (ASX:SEQ) CEO and Managing Director Garry Crole discusses the 80 per cent sale of Morrison Securities to New Quantum.
